Considerable insight into the folding and unfolding pathways of a protein can be obtained from trapping and characterizing intermediates involved in the dynamic process (1) (2) (3) (4) . Disulfide-containing proteins provide an opportunity to capture thiol-containing intermediates by chemical reaction during the time course of folding or unfolding (5) (6) (7) (8) . The detailed folding pathways of several proteins (9 -11) have been studied in this way, including bovine pancreatic trypsin inhibitor (6, 8, 12, 13) and ribonuclease A (14 -18) .
To isolate and characterize intermediates that are involved in folding or unfolding of proteins containing disulfide bonds, it is necessary to stop thiol/disulfide exchange reactions that convert one intermediate to another. One traditional approach involves trapping of thiol groups irreversibly by alkylation with iodoacetate, iodoacetamide, or vinylpyridine under alkaline conditions. However, rearrangement of intermediates during the trapping procedure with iodoacetate has been observed for both bovine pancreatic trypsin inhibitor (8) and ribonuclease A (19, 20) . Another traditional method quenches thiol/disulfide exchange by lowering the pH to Յ2 by acidification. An advantage of acid quenching is its reversibility; intermediates trapped at low pH can be isolated and allowed to undergo further rearrangement or refolding after readjusting the pH in experiments designed to more completely characterize particular pathways (8, 10) . While quenching by acidification occurs at a diffusion-controlled rate, it does not completely stop thiol/ disulfide exchange (21) ; further chemical modification is also necessary for the structural characterization of an acid-trapped intermediate.
We recently developed a methodology to trap folding intermediates based on the cyanylation of thiol groups by 1-cyano-4-dimethylaminopyridinium (CDAP) 1 tetrafluoroborate under acidic conditions (22) . This approach has several unique advantages. First, cyanylation of thiol groups in acidic solution quenches the refolding process and minimizes thiol/disulfide exchange. Second, cyanylation of thiol is already part of our procedure for structural elucidation of the intermediates, which involves partial reduction, cyanylation, chemical cleavage, and mass mapping (22, 23) . Third, this methodology is fast, simple, and even applicable to disulfide structural analysis of proteins containing adjacent cysteines (24) .
Insulin-like growth factor-I (IGF-I) (25) is a single-chain polypeptide of 70 residues containing three intramolecular disulfide bonds, two of which involve adjacent cysteines (Fig. 1) . IGF-I is postulated to be the mediator of growth hormone action on skeletal tissue as well as of mitogenic activity on several cell types (26, 27) . The refolding of IGF-I has been studied by several groups (28 -32 (29, 30) ; in addition to the four intermediates detected by pyridylethylation, a nonnative two-disulfide species and a mixed two-disulfide intermediate with GSH were also detected. Furthermore, a different equilibrium distribution of intermediates was obtained by each of the two trapping procedures.
It has been documented that the oxidative refolding of IGF-I follows a pathway governed by thermodynamic rather than kinetic principles, resulting in two folding isomers of similar thermodynamic stability but different disulfide conformations (native and mismatched isomers) (28 -32) . Milner et al. (33) proposed that a salt bridge between Glu 3 and Arg 56 in IGF-I might stabilize the mismatched isomer, accounting for the observation of more than one folding outcome of IGF-I.
Recombinant human long R 3 insulin-like growth factor-I (LR 3 IGF-I) is a variant of human insulin-like growth factor-I (IGF-I) in which glutamate 3 is replaced by arginine, and a 13-residue extension appears at the N terminus (Fig. 1) . LR 3 IGF-I is substantially more potent than IGF-I in affecting carbohydrate metabolism and in stimulating the growth of fetal tissue in animals (34) . The refolding behavior of LR 3 IGF-I has been described as being significantly different from that of IGF-I (33); however, in that preliminary report, neither the disulfide structure of the intermediates nor the folding pathway of LR 3 IGF-I was determined. We report here on important aspects of the folding pathway of both LR 3 IGF-I and IGF-I by structural elucidation of disulfide intermediates involved in the folding and unfolding processes. Our results were obtained using cyanylation chemistry for trapping intermediates and specific cleavage/mass mapping for subsequent structural elucidation of the intermediates (22) (23) (24) . Similarities and differences in the folding patterns of LR 3 IGF-I and IGF-I are highlighted and rationalized on the basis of their structures.
EXPERIMENTAL PROCEDURES
Materials-Recombinant human long R 3 insulin-like growth factor-I (LR 3 IGF-I) was purchased from Sigma. IGF-I was obtained from Austral Biologicals (San Ramon, CA). The proteins were purified prior to use by reversed phase HPLC as described below. Tris(2-carboxyethyl)phosphine hydrochloride was purchased from Pierce. Guanidine hydrochloride was obtained from Roche Molecular Biochemicals. GSSG, GSH, citric acid, sodium citrate, hydrochloric acid, and CDAP were purchased from Sigma and used without further purification. Acetonitrile and trifluoroacetic acid were of HPLC grade. Tris(2-carboxyethyl)phosphine solution in 0.1 M citrate buffer at pH 3.0 was prepared as 0.10 M stock solution and stored under N 2 at -20°C for weeks with little deterioration. The 0.10 M CDAP solution in 0.1 M citrate buffer at pH 3.0 was prepared prior to use.
Refolding of Reduced/Unfolded Proteins-An overall scheme representing the refolding (and reductive unfolding) protocol is shown in Fig. 2 . LR 3 IGF-I or IGF-I (0.1 mg) was dissolved in 0.5 ml of citrate buffer, pH 3.0, containing 6 M guanidine-HCl and 0.1 M Tris(2-carboxyethyl)phosphine reducing agent. Reduction of the proteins was carried out at 37°C for 2 h; the reduced/ denatured LR 3 IGF-I or IGF-I was purified by HPLC, dried under reduced pressure, and stored at Ϫ70°C.
The refolding of reduced and denatured protein was initiated by diluting the reduced/unfolded protein sample with 0.10 M Tris-HCl buffer (pH 8.7), containing 1 mM GSSG, 10 mM GSH, 0.2 M KCl, and 1 mM EDTA, to a final protein concentration of 0.1 mg/ml. The refolding intermediates were trapped at different times by the method described below.
Reductive Unfolding of Native Proteins-Native LR 3 IGF-I or IGF-I (0.1 mg/ml) was reduced/unfolded in 0.10 M Tris-HCl buffer, pH 8.7, containing 0.25 mM cysteine, 0.20 M KCl, and 1.0 mM EDTA. After incubation for the indicated periods, an aliquot of reductive/unfolding solution (0.1 ml) was removed, and the intermediates were trapped, separated, and analyzed by the method described below. After the reductive unfolding reached the equilibrium, cysteine was added to a final concentration of 100 mM to drive the reductive unfolding reaction to completion. 3 IGF-I-Refolding of the reduced, unfolded LR 3 IGF-I was quenched at 30 min by adding 1.0 M HCl to pH ϳ2. After HPLC separation, the fractions containing a two-disulfide intermediate and a mismatched (three-disulfide) protein isomer were dried; reconstituted in 0.10 M Tris-HCl buffer (pH 8.7) containing 1 mM GSSG, 10 mM GSH, 0.2 M KCl, and 1.0 mM EDTA to a final concentration of 0.1 mg/ml; and incubated for up to 30 min at room temperature. At designated time points, aliquots were removed, and refolding intermediates were trapped by the method described below.
Refolding of Isolated Specific Folding Intermediates of LR
Trapping of Intermediates-Refolding or reductive unfolding intermediates were trapped in a time course manner by removing aliquots (0.1 ml) of protein solution and mixing with 1.0 M HCl containing freshly prepared 0.2 M CDAP to give a solution of pH 2-3. Cyanylation of free thiol groups by the CDAP proceeded at room temperature for 10 min. The trapped intermediates were immediately separated by HPLC under the conditions described below. The HPLC fractions were collected manually and analyzed by MALDI-time-of-flight mass spectrometry. Those with 0-, 52-, 104-, or 156-Da increases over the mass of the intact protein correspond to three-disulfide (native or nonnative), two-disulfide, one-disulfide, and the completely reduced species, respectively. A mass shift of ϩ306 Da is characteristic of the formation of a mixed disulfide bond between a thiol group and glutathione; a mass shift of ϩ612 Da indicates 
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the presence of two mixed disulfide bonds with two glutathiones.
Structural Elucidation of Disulfide Intermediates-The disulfide structure of purified refolding or reductive unfolding intermediates was determined by the partial reduction/cyanylation/chemical cleavage/mass mapping approach, as described previously (22, 23) .
HPLC Separation-The separation of folding/unfolding intermediates was carried out by reversed phase HPLC with a linear gradient elution using Waters model 6000 pumps controlled by a PC. The UV detection was at 215 nm. The column was a Vydac C18 (catalog no. 218TP54; 10-m particle size, 300-Å pore, 4.6 ϫ 250 mm). Solvent A was 0.1% aqueous trifluoroacetic acid. Solvent B was acetonitrile/water (9:1, v/v) containing 0.1% trifluoroacetic acid. The linear gradient was 30 -50% solvent B in 45 min at a flow rate of 1 ml/min. The HPLC fractions were collected manually, and the contents were then dried under reduced pressure for further use.
Mass Spectrometry-MALDI mass spectra were obtained on a Voyager Elite time-of-flight mass spectrometer (PerSeptive Biosystems Inc., Framingham, MA) equipped with delayed extraction and a model VSL-337ND nitrogen laser (Laser Science, Newton, MA). The accelerating voltage in the ion source was set to 20 kV. Grid and guide wire voltages were 93.6 and 0.2% of the accelerating voltage, respectively. Data were acquired in the positive linear DE mode of operation. Time-tomass conversion was achieved by external and/or internal calibration using standards of bradykinin (m/z 1061.2), bovine pancreatic insulin (m/z 5734.5), and horse skeletal myoglobin (m/z 16952) obtained from Sigma. All experiments were performed using ␣-cyano-4-hydroxycinnamic acid (Aldrich) as the matrix. Saturated matrix solutions were prepared in a 50% (v/v) solution of acetonitrile/aqueous 1% trifluoroacetic acid, mixed in equal volumes with peptide or protein samples, and applied to a stainless steel sample plate. The mixture was allowed to air-dry before being introduced into the mass spectrometer. 3 IGF-I and IGF-I-The distribution of intermediates during the refolding process is represented by HPLC chromatograms of cyanylated species trapped at designated times. Fig. 3 , a and b, shows an array of chromatograms of LR 3 IGF-I and IGF-I intermediates trapped by reaction with CDAP under acidic conditions at various times after initiating refolding in the GSSG/GSH buffer. In addition to native LR 3 IGF-I (N) and completely reduced LR 3 IGF-I (R), three well populated species were observed at different time points during the refolding of LR 3 IGF-I (Fig. 3a) . The oxidative state of the trapped intermediates was determined by MALDI mass spectrometry based on the mass shift between intermediate and the intact protein.
RESULTS

Temporal Distribution of Refolding Intermediates of LR
Thus, peaks IЈ and IIЈ in Fig. 3a correspond to intermediates containing one and two disulfide bonds, respectively, as evidenced by 104-and 52-Da shifts from the mass of the intact protein. Peak IIIЈ represents a mixture of a mismatched threedisulfide intermediate (the same mass as intact protein) and a mixed two-disulfide intermediate in which two SH groups each formed a mixed disulfide bond with a glutathione (as indicated by a shift of ϩ612 Da from the mass of the intact protein).
Reduced/unfolded LR 3 IGF-I was first converted to a onedisulfide intermediate (peak IЈ) and then a two-disulfide intermediate (peak IIЈ) within 1 min in the presence of 10 mM GSH, 1 mM GSSG. The three-disulfide intermediate and mixed twodisulfide intermediate coeluted as peak IIIЈ by 2 min. Considerable native protein (N) was formed by 30 min, a time by which an equilibrium had been reached, and the ratio of the mismatched and native protein remained constant thereafter. Fig. 3b shows the HPLC trace of refolding intermediates of IGF-I trapped at 10 s, 1 min, 2.5 min, and 30 min, respectively.
FIG. 3. HPLC chromatogram showing the time-dependent distribution of CDAP-trapped intermediates during the refolding of LR 3 IGF-I (a) and IGF-I (b). See "Experimental Procedures" for HPLC conditions.
During the course of refolding, a total of six well populated intermediates were trapped and identified. Mass analysis by MALDI showed that peak III represents a mismatched protein isomer containing three disulfide bonds; peaks II A , II B , and II C are two-disulfide intermediates; peak II mix represents a mixed two-disulfide species with two glutathiones; and peak I is a one-disulfide species. The intermediate distribution at equilibrium (see bottom panel) is very similar to that previously reported from a study using acidic quenching (29, 30) .
Temporal Distribution of Reductive Unfolding Intermediates of LR
3 IGF-I and IGF-I-In order to prevent the formation of mixed disulfide intermediates as would occur with GSH/GSSG in the refolding process, the reductive unfolding of both proteins was performed in cysteine solution. The time-dependent distribution of the CDAP-trapped intermediates during reductive unfolding of LR 3 IGF-I is shown in Fig. 4a . The pattern of intermediates was the same (but inverted) as that observed during the refolding of LR 3 IGF-I. The mismatched three-disulfide isomer was observed as the earliest intermediate, accounting for ϳ10% of the total protein at 3 h. Prolonged incubation of up to 71 h did not alter the ratio of the native and mismatched protein isoforms, suggesting that the native and mismatched species had reached a state of equilibrium. However, the twodisulfide intermediate IIЈ did accumulate during the incubation. After 71 h of incubation, thermodynamic equilibrium among the three species had been reached. When the concentration of cysteine was increased to 100 mM and the mixture was incubated for another 30 min after reaching the 71-h equilibrium point under the initial conditions, the completely reduced/unfolded protein (R) became the predominant species, accompanied by only minor amounts of two-and one-disulfide intermediates.
The reductive unfolding of IGF-I under the same conditions (Fig. 4b) showed a similar pattern to that of LR 3 IGF-I, but the ratio of the mismatched isomer at equilibrium was significantly higher (35%) than that (10%) observed during the unfolding of LR 3 IGF-I. Unlike the refolding of IGF-I in which many more intermediates were observed at thermodynamic equilibrium, during reductive unfolding of IGF-I the mismatched threedisulfide species appeared as the only early intermediate to reach an equilibrium with the native protein within 2 h. Further incubation up to 20 h did not significantly change the pattern of unfolding intermediates. Apparently, the trace of cysteine (0.25 mM) in the solution was insufficient to effect further reduction of the disulfide bonds. Increasing the cysteine concentration to 100 mM and incubating for another 1 min shifted the equilibrium distribution of intermediates of IGF-I to the pattern shown in the bottom panel of Fig. 4b ; both the one-disulfide intermediate (I) and the two-disulfide intermediate (II A ) (but not II B and II C ) were formed within 1 min. After 30 min, II A and I were almost completely converted to reduced/ unfolded IGF-I (R) (data not shown).
Refolding from Intermediates IIЈ and IIIЈ of LR 3 IGF-I-The refolding intermediates of LR 3 IGF-I (corresponding to peaks IIЈ and IIIЈ in Fig. 3a , respectively) were trapped during a separate experiment by acid quenching and purified by HPLC. Secondary refolding experiments were initiated with each of these purified acid-trapped intermediates by reconstituting them in 10 mM GSH, 1 mM GSSG buffer, pH 8.7, for up to 30 min at room temperature. HPLC trace of the refolding intermediates from IIIЈ (Fig. 5b) showed a partially resolved peak from IIIЈ. Analysis of the corresponding material indicated a molecular weight increase of ϳ612 Da, which identified it as a glutathione adduct containing two glutathiones per LR 3 IGF-I. Structural Elucidation of Disulfide Intermediates-The methodology developed in our laboratory (22) (23) (24) , based upon chemical cleavage at cyanylated cysteine residues and subsequent mass mapping of the fragments, was employed to determine the disulfide structure of the trapped intermediates. The disulfide structures of the respective folding intermediates are summarized in Table I . (29, 30) . By mass mapping the cleavage products resulting from cyanylated intermediates, the disulfide structures of six well populated intermediates were identified, including a native one-disulfide intermediate ( (28) , while it was the minor form in the distribution of the folding intermediates trapped by the CDAP approach described herein and also by acid trapping as reported elsewhere (29, 30) .
In order to compare the flow of intermediates in the folding pathway of LR 3 IGF-I and IGF-I, the refolding of both LR 3 IGF-I and IGF-I was performed under identical conditions in a GSSG/ GSH buffer. Comparison of the HPLC pattern of folding intermediates for LR 3 IGF-I and IGF-I exhibited some similarities and discrepancies. All the trapped intermediates contain a native Cys 18 -Cys 61 structure, which is the first disulfide bond formed in the refolding process (Fig. 3, a and b) and the last disulfide bond reduced in the unfolding process (Fig. 4, a and  b) . (Table I) . Furthermore, the formation of early intermediates in IGF-I is much faster; at 2.5 min, ϳ90% of the reduced IGF-I is oxidized, whereas only ϳ50% of the reduced LR 3 IGF-I is oxidized in the same time period. Nevertheless, an equilibrium distribution of intermediates can be reached for both proteins within 30 min.
Rosenfeld et al. (31) Three distinct features are recognized after comparing the unfolding processes of LR 3 IGF-I and IGF-I. First, the conversion of native IGF-I to the three-disulfide intermediate III (Fig.  4b) is faster than the conversion of native LR 3 IGF-I to the three-disulfide intermediate IIIЈ (Fig. 4a) . Second, no apprecia- 
